BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: He SY, Lin QF, Chen J, Yu GP, Zhang JL, Shen D. Efficacy of afatinib in a patient with rare EGFR (G724S/R776H) mutations and amplification in lung adenocarcinoma: A case report. World J Clin Cases 2021; 9(6): 1329-1335 [PMID: 33644199 DOI: 10.12998/wjcc.v9.i6.1329]
URL: https://www.wjgnet.com/2307-8960/full/v9/i6/1329.htm
Number Citing Articles
1
Nian Yu, Yinghui Xu, Xu Wang, Chao Sun, Shi Qiu, Ye Guo, Miao Bai, Yanxin Huang, Kewei Ma. Successful Treatment of Afatinib Reversing Epidermal Growth Factor Receptor Exon19Deletion/G724S Mutation Resistance Guided by Protein-Drug DockingThe Oncologist 2021; 26(11): e1903 doi: 10.1002/onco.13932
2
Teng Li, Shouzheng Wang, Jianming Ying, Yan Wang, Xingsheng Hu, Xuezhi Hao, Ziyi Xu, Puyuan Xing, Junling Li. Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutationsThoracic Cancer 2021; 12(21): 2924 doi: 10.1111/1759-7714.14156